Sandeep Dhindsa is an Endocrinology/Metabolic physician affiliated with Saint Louis University Hospital. OpenAlex indexes 162 publications with 6,741 citations (h-index 37); ClinicalTrials.gov lists 2 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1225 S Grand Blvd Fl 2
Saint Louis, MO 631041016
Telephone
314-977-7330Provider last certified this registry record 26 Jan 2021.
Clinical trials
- Testosterone Treatment in Men With Chronic Kidney Disease
Sponsor: St. Louis University
- Insulin Resistance Following ADT for Prostate CA
Sponsor: St. Louis University
- Effect of Transgender Therapy on Muscle, Fat and Tissue Receptors
Sponsor: St. Louis University
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
23 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Verity Pharmaceuticals Inc.Program year20253 payments
- Revvity, Inc.Program year20251 payment
- Novo Nordisk IncProgram year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
64%GLP-1 receptor agonist22.8%Ozempic49%Mounjaro30%Trulicity21%Part D≥49 patientsInsulin Analog15.1%Lantus Solostar30%Humalog Kwikpen U-10013%Basaglar Kwikpen U-10012%Humalog7%Fiasp Flextouch6%Novolog Flexpen6%Tresiba Flextouch U-1006%Insulin Lispro5%Insulin Lispro Kwikpen U-1005%Insulin Aspart Flexpen5%Tresiba Flextouch U-2005%Part D<11 patients+ 5 more classes in this area
Hormonal (systemic)
15.4%l-Thyroxine13.4%Levothyroxine Sodium94%Synthroid6%Part D<11 patientsThyroid Hormone Synthesis Inhibitor1.3%Methimazole100%Part D<11 patients+ 1 more class in this area
Genitourinary & hormones
9.2%Androgen8.6%Testosterone63%Testosterone Cypionate38%Part D≥22 patientsEstrogen Agonist/Antagonist0.6%Clomid100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Mechanisms underlying the metabolic actions of testosterone in humans: A narrative review
Diabetes Obesity and Metabolism
2020 - Low Testosterone Is Associated With Nonalcoholic Steatohepatitis and Fibrosis Severity in Men
Clinical Gastroenterology and Hepatology
2019
Similar KOLs
Other experts from the same institution or the same specialty.
Hersh Maniar, MD
Saint Louis University Hospital
Preben Bjerregaard, MD
Saint Louis University Hospital
Medhat Osman, MD
Saint Louis University Hospital
Stewart Albert, MD
Saint Louis University Hospital
Jens J. Holst
University of Copenhagen
Victor Montori, MD
Mayo Clinic
Daniel J. Drucker
University of Toronto
Kenneth Cusi, MD
University of Florida College of Medicine
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”